16B. ASRH Invited Speaker Session: Discovery and Translational Science: Antimicrobial resistance in the era of doxycycline post-exposure prophylaxis
Tracks
Track 2
| Thursday, September 18, 2025 |
| 1:30 PM - 3:00 PM |
| City Room 1&2 (Upper Level) |
Details
The efficacy of doxycycline post-exposure prophylaxis for prevention of bacterial sexually-transmitted infections (STIs) in men who have sex with men demonstrated in multi-centre randomised clinical trials is a promising intervention for improved control of STIs. This session aims to investigate the potential impacts of doxycycline on antimicrobial resistance in STIs and commensal bacteria.
All Q&A at the end of the session
Speaker
Dr Emma Sweeney
Senior Research Fellow
The University Of Queensland
Potential impacts of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae AMR and novel molecular strategies for antimicrobial surveillance and resistance-guided management
1:30 PM - 1:50 PMBiography
Emma Sweeney is a senior research fellow at The University of Queensland Centre for Clinical Research. Her research interests include the development of novel molecular tools to detect and characterise pathogens of global health importance, with a particular focus on the sexually transmitted infection (STI) superbug Mycoplasma genitalium.
Dr Gerald Murray
Research Officer
The University of Melbourne
Resistance in Mycoplasma genitalium
1:50 PM - 2:10 PMBiography
Ms Nicole Lima
Research Manager
SpeeDx
Viability testing and potential impacts on antimicrobial usage and antimicrobial resistance
2:10 PM - 2:30 PMBiography
Nicole Lima, a Research Manager at SpeeDx Pty Ltd, has 13 years of experience in the development of innovative molecular diagnostics. Alongside Dr. Alison Todd, Nicole co-invented a patented viability testing technology (InSignia) for assessing viability and antibiotic susceptibility in bacteria. Nicole and her team of scientists are currently focused on continual development and validation this test for STIs, including demonstrating the clinical utility within the current landscape.
ASRH Session Chair
Eloise Williams
Clinical Microbiologist and Infectious Diseases Physician
Victorian Infectious Diseases Reference Laboratory
